Shanghai, China

Qiao Zhao

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 7.4

ph-index = 3

Forward Citations = 22(Granted Patents)


Company Filing History:


Years Active: 2017-2024

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Qiao Zhao: Innovator in Guanylate Cyclase C Agonists

Introduction

Qiao Zhao is a prominent inventor based in Shanghai, China. She has made significant contributions to the field of biochemistry, particularly in the development of ultra-pure agonists of guanylate cyclase C. With a total of nine patents to her name, her work has the potential to impact therapeutic approaches in various medical conditions.

Latest Patents

Among her latest patents is the invention titled "Ultra-pure agonists of guanylate cyclase C, method of making and using same." This invention provides processes for purifying a peptide that includes a guanylate cyclase C agonist sequence. The processes involve a solvent exchange step prior to a freeze-drying (lyophilization) step. This innovative approach enhances the purity and efficacy of the agonists, which could lead to improved therapeutic outcomes.

Career Highlights

Qiao Zhao has worked with notable companies in the pharmaceutical industry, including Bausch Health Ireland Limited and Synergy Pharmaceuticals, Inc. Her experience in these organizations has allowed her to refine her expertise in drug development and peptide purification.

Collaborations

Throughout her career, Qiao has collaborated with esteemed colleagues such as Kunwar Shailubhai and Stephen Comiskey. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Qiao Zhao's contributions to the field of biochemistry through her patents and collaborations highlight her role as a leading inventor. Her work on guanylate cyclase C agonists showcases the potential for advancements in medical therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…